3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Metabolic Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiarugi, M; Ferrannini, E; Madec, S; Rossi, C; Salvati, A; Santini, E; Solini, A | 1 |
1 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Metabolic Syndrome
| Article | Year |
|---|---|
Adipocyte P2X7 receptors expression: a role in modulating inflammatory response in subjects with metabolic syndrome?
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Adipocytes; Aged; Blotting, Western; Calcium Signaling; Case-Control Studies; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Inflammasomes; Inflammation; Inflammation Mediators; Interleukin-6; Intra-Abdominal Fat; Italy; Metabolic Syndrome; Middle Aged; Plasminogen Activator Inhibitor 1; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Real-Time Polymerase Chain Reaction; Receptors, Purinergic P2X7; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Subcutaneous Fat; Tumor Necrosis Factor-alpha; Up-Regulation | 2011 |